Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001714899-22-000038
Filing Date
2022-02-14
Accepted
2022-02-14 20:32:15
Documents
2
Period of Report
2022-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 3/A wf-form3a_164488871184004.html 3/A  
1 FORM 3/A wf-form3a_164488871184004.xml 3/A 1849
2 POWER OF ATTORNEY FOR: /S/ TYLER NIELSEN, BY POWER OF ATTORNEY poa.htm EX-24 2179
  Complete submission text file 0001714899-22-000038.txt   5388
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
Harris Erik (Reporting) CIK: 0001780113 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-38311 | Film No.: 22636582